Extracorporeal Life Support Registry Report 2004
Extracorporeal Life Support Registry Report 2004
复制标题
DOI：
10.1097/01.mat.0000151922.67540.e9
复制
发表时间：
2005-01-01
期刊：
影响因子：
4.2
通讯作者：
Dalton, H
中科院分区：
文献类型：
--
作者：
Conrad, SA;Rycus, PT;Dalton, H
在这篇文章中，数据来自年度国际非放射性生命支持组织（ELSO）登记报告，截至2004年7月。近29，000名患者接受了体外生命支持（ECLS）。在这些患者中，66%（超过19，000例）为新生儿呼吸衰竭，出院或转院的总生存率为77%。向登记处报告的新生儿呼吸道病例数已从1992年的1 500例高峰下降到每年约800例。自1993年以来，儿科呼吸道病例的数量保持在每年约200例，出院或转院的存活率为56%。成人呼吸衰竭仍然是接受体外膜肺氧合（ECMO）治疗的最小年龄组，每年不到100例。然而，出院存活率与小儿呼吸衰竭相当（53%）。在所有年龄组中，心力衰竭的支持率继续增加，新生儿、儿科和成人的存活率分别为38%、43%和33%。在过去5年中，ECLS支持的儿童和成人呼吸衰竭病例的生存率保持相当一致。
In this article, data from the annual international Extracorporeal Life Support Organization (ELSO) Registry Reports through July 2004 are presented. Nearly 29,000 patients have received extracorporeal life support (ECLS). Of the patients, 66% (more than 19,000) were neonatal respiratory failure, with a 77% overall survival to discharge or transfer. The number of neonatal respiratory cases reported to the Registry has decreased from a peak of 1,500 patients in 1992 and has leveled off at approximately 800 cases per year. The number of pediatric respiratory cases has remained at approximately 200 cases per year since 1993, with a 56% survival to discharge or transfer. Adult respiratory failure continues to be the smallest age group treated with extracorporeal membrane oxygenation (ECMO), with less than 100 cases per year. Survival to discharge, however, is comparable with pediatric respiratory failure (53%). Support continues to increase for cardiac failure across all age groups, with survival to discharge rates of 38%, 43%, and 33% for neonatal, pediatric, and adults, respectively. Survival in pediatric and adult respiratory failure cases supported with ECLS has remained fairly consistent over the past 5 years.